MyOme is an innovative clinical whole genome analysis platform that aids families in understanding inherited disease risks. Specializing in polygenic modeling, the company harnesses whole genome data to provide actionable insights for a lifetime, driving advancements in healthcare technology, biotechnology, and data analytics.
Specialties
Whole Genome Sequencing
Polygenic Risk Modeling
On-Demand Health Insights
Machine Learning Integration
Actionable Genetic Analysis
Products & Services
Whole Genome Sequencing
Polygenic Risk Analysis
Personal Genome Insights
Disease Risk Assessment
Dynamic Health Updates
Contact Information
No contact information available
Competitors & Similar Companies(10)
23andMe
California, • United States
AncestryDNA
Utah, • United States
Invitae
California, • United States
GeneDx
New Jersey, • United States
Myriad Genetics
Utah, • United States
Guardant Health
California, • United States
Fulgent Genetics
California, • United States
Color Genomics
Sema4
Fabric Genomics
California, • United States • Internet and Technology
AI-driven genomic analysis, Whole genome and exome sequencing, Clinically actionable insights, Data analytics for genomics, Healthcare technology solutions
News & Media
Search Terms:
myome
Search Topics:
AcquisitionAI: Product LaunchInvestment: Approval FundingProject: Bid and AuctionBusiness ExpansionFinancing and FundraisingInvestmentJoint VentureLeadership Change (CXO)MergerPartnershipProduct LaunchPublic Offering (IPO)RebrandingReorganizationRestructuringValuation
Loading...
Frequently Asked Questions about MyOme
Where is MyOme located?
The headquarter of MyOme is located in Palo Alto, California, United States
MyOme belongs to the Healthcare Technology, Biotechnology, Data Analytics and Business Intelligence, Biotechnology and Life Sciences industry.
What are the specialties of MyOme?
MyOme specializes in Whole Genome Sequencing, Polygenic Risk Modeling, On-Demand Health Insights, Machine Learning Integration, Actionable Genetic Analysis.
What products and services is MyOme likely to offer?
MyOme offers Whole Genome Sequencing, Polygenic Risk Analysis, Personal Genome Insights, Disease Risk Assessment, Dynamic Health Updates.
Who are the competitors of MyOme?
Competitors of MyOme are 23andMe, AncestryDNA, Invitae, GeneDx, Myriad Genetics, Guardant Health, Fulgent Genetics, Color Genomics, Sema4, Fabric Genomics.
What does MyOme do?
MyOme is an innovative clinical whole genome analysis platform that aids families in understanding inherited disease risks. Specializing in polygenic modeling, the company harnesses whole genome data to provide actionable insights for a lifetime, driving advancements in healthcare technology, biotechnology, and data analytics.